GlassScriptPhysician profile
Henri M Pierre Jacques
NPI 1548231384
$2,046.76
in general payments reported to CMS, 2019-2025
14 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $256 · 2021: $961 · 2022: $66.69 · 2023: $22.34 · 2024: $117 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $715.29 | 2019-2025 | Tapestry, Activbraid |
| Stryker Corporation | $363.34 | 2019-2024 | Mako |
| Medacta USA, INC. | $349.81 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $347.34 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.21 | 2019 | |
| Urgo Medical North America, LLC | $47.47 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Electronic Waveform Lab, INC. | $28.15 | 2025 | |
| Depuy Synthes Sales INC. | $26.76 | 2019 | |
| Heron Therapeutics, INC. | $22.34 | 2023 | Zynrelef |
| Medical Device Business Services, INC. | $19.91 | 2019 | |
| Bioventus LLC | $16.72 | 2022 | |
| Linvatec Corporation | $14.43 | 2024 | Hall Power |
| Ferring Pharmaceuticals INC. | $13.00 | 2022 | |
| Ermi LLC | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henri Pierre Jacques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.